0000000000213231

AUTHOR

Markus Meissner

showing 4 related works from this author

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis

2018

Basal cell carcinoma is the most common malignant tumor among fair-skinned individuals, and its incidence has been rising steadily in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 1 highlights new developments in genetics in particular as well as aspects regarding epidemiology, diagnosis, and histology.

Geneticsmedicine.medical_specialtyMolecular epidemiologybusiness.industryIncidence (epidemiology)MEDLINEDermatologyDiseasemedicine.disease3. Good health030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineEpidemiologymedicineCarcinomaBasal cell carcinomaProfessional associationbusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outco…

2005

AbstractPurpose: Human leukocyte antigen (HLA) class I antigen defects, which are frequently present in head and neck squamous cell carcinoma (HNSCC) cells may provide the tumor with an escape mechanism from immune surveillance. Scanty information is available about mechanisms underlying HLA class I antigen defects in both lesions and cell lines from HNSCC. In this study, we investigate the role of antigen processing machinery (APM) component abnormalities in the generation of deficient HLA class I surface expression of HNSCC cells.Experimental Design: Using immunohistochemistry, Western blot, and RT-PCR analyses we correlated the expression of the IFN-γ inducible proteasome subunits and of…

AdultMaleProteasome Endopeptidase ComplexCancer ResearchPathologymedicine.medical_specialtyBlotting WesternDown-RegulationHuman leukocyte antigenBiologyCell LineInterferon-gammaATP Binding Cassette Transporter Subfamily B Member 3HLA AntigensMultienzyme ComplexesCell Line TumorTumor Cells Culturedotorhinolaryngologic diseasesmedicineCarcinomaHumansATP Binding Cassette Transporter Subfamily B Member 2AgedReverse Transcriptase Polymerase Chain ReactionAntigen processingHistocompatibility Antigens Class ICancerMiddle Agedmedicine.diseaseImmunohistochemistrySurvival AnalysisHead and neck squamous-cell carcinomaGene Expression Regulation NeoplasticCysteine Endopeptidasesstomatognathic diseasesOncologyHead and Neck NeoplasmsCarcinoma Squamous Cellbiology.proteinImmunohistochemistryTAP2ATP-Binding Cassette TransportersFemaleTAP1Clinical Cancer Research
researchProduct

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as we…

2008

Summary Background  Abnormalities of the major histocompatibility complex (MHC) antigens by tumour cells impair the cellular immune response and promote tumour evasion from immune surveillance. So far, studies analysing the MHC class II expression levels in head and neck cancer have been limited. Objectives  Therefore, we investigated the constitutive and interferon (IFN)-γ-regulated expression profiles of MHC class II antigen processing machinery (APM) in various head and neck cancer cell lines and also analysed the MHC class II expression in head and neck cancer lesions. Methods  Using immunohistochemistry, flow cytometry, and reverse transcriptase-polymerase chain reaction analyses we in…

AdultCD4-Positive T-LymphocytesMaleTranscription Geneticchemical and pharmacologic phenomenaDermatologyMajor histocompatibility complexMHC class II antigenInterferon-gammaAntigenCell Line TumorMHC class ICIITAmedicineHumansRNA Processing Post-TranscriptionalAgedMHC class IIAntigen PresentationbiologyAntigen processingReverse Transcriptase Polymerase Chain ReactionHistocompatibility Antigens Class IICancerMiddle Agedmedicine.diseaseFlow CytometryImmunohistochemistryHead and Neck Neoplasmsbiology.proteinCancer researchCarcinoma Squamous CellFemale
researchProduct

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up

2019

Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

medicine.medical_specialtybusiness.industryIncidence (epidemiology)MEDLINEDermatologyDiseasemedicine.disease3. Good health030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineCarcinomaProfessional associationBasal cell carcinomaDisease management (health)Intensive care medicineRisk assessmentbusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct